PSIX:NASDAQPower Solutions International, Inc. Analysis
Data as of 2026-06-26 - not real-time
$38.71
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Power Solutions International (PSIX) is trading at $38.71, well above its DCF-derived fair value of $8.55, indicating a significant overvaluation despite a low trailing PE of 8.7 versus an industry average of 32. Technicals point to a bearish backdrop – the 20‑day SMA sits at 39.67 and the 50‑day SMA at 52.96, both above the current price, while the 200‑day SMA remains at 69.27. Momentum is mixed: RSI is near 40 (oversold territory) and the MACD histogram is positive, suggesting short‑term bullish pressure, yet the overall trend is still bearish with decreasing volume and a high beta of 3.2 and 84% 30‑day volatility.
Fundamentally, PSIX posted revenue of $715.6 M (down 5.1% YoY) and net income of $102.2 M**, but its balance sheet is strained with a debt‑to‑equity ratio near 91% and negative free cash flow. The company offers no dividend, and while margins are modest (24% gross, 9% operating), the high ROE of 75% reflects a thin equity base rather than sustainable earnings power. Recent news highlights a sharp share‑price decline of 40% over the past month, underscoring heightened market skepticism.
Fundamentally, PSIX posted revenue of $715.6 M (down 5.1% YoY) and net income of $102.2 M**, but its balance sheet is strained with a debt‑to‑equity ratio near 91% and negative free cash flow. The company offers no dividend, and while margins are modest (24% gross, 9% operating), the high ROE of 75% reflects a thin equity base rather than sustainable earnings power. Recent news highlights a sharp share‑price decline of 40% over the past month, underscoring heightened market skepticism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near support at $36.6 with limited upside to $43.2
- Mixed technical signals (RSI low, MACD bullish histogram)
- High volatility and beta increase short‑term risk
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Low PE vs industry suggests value appeal
- Revenue contraction and high debt‑to‑equity raise concerns
- Absence of dividend and negative free cash flow limit upside
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Overvaluation relative to DCF fair value
- Sustained revenue decline and leverage risk
- Cyclical industrial exposure and high beta amplify long‑term uncertainty
Key Metrics & Analysis
Financial Health
Revenue Growth-5.10%
Profit Margin14.28%
P/E Ratio8.7
ROE75.67%
ROA15.01%
Debt/Equity90.88
P/B Ratio4.8
Op. Cash Flow$34.4M
Free Cash Flow$-188000
Industry P/E32.0
Technical Analysis
TrendBearish
RSI39.9
Support$36.60
Resistance$43.23
MA 20$39.67
MA 50$52.96
MA 200$69.27
MACDBullish
VolumeDecreasing
Fear & Greed Index85.36
Valuation
Fair Value$8.55
Target Price$70.37
Upside/Downside81.78%
GradeOvervalued
TypeValue
Risk Assessment
Beta3.19
Volatility84.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.